Morbidity rate of drug-susceptible tuberculosis and its medico-economic impact (original) (raw)

Factors associated with mortality in patients with tuberculosis

jose CASTILLO PAREDES

BMC Infectious Diseases, 2010

View PDFchevron_right

Monitoring for adverse events among patients on tuberculosis therapy

David Michail

New South Wales Public Health Bulletin, 2013

View PDFchevron_right

Global Epidemiology of Tuberculosis

Mario Raviglione

Clinics in Chest Medicine, 2005

View PDFchevron_right

The joint Médecins Sans Frontières/Ministry of Health multidrug-resistant tuberculosis

Dilrabo ulmasova

2016

View PDFchevron_right

Tuberculosis and noncommunicable diseases: neglected links and missed opportunities

Mario Raviglione

European Respiratory Journal, 2010

View PDFchevron_right

Drug-resistant tuberculosis: A disease of target populations in Houston, Texas

Larry D Teeter

Journal of Infection, 2006

View PDFchevron_right

Burden of Tuberculosis and Challenges Facing Its Eradication in West Africa

Aniekan Ekpenyong

International Journal of Infection, 2019

View PDFchevron_right

Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria

Ahmad Habibu

PLOS ONE, 2019

View PDFchevron_right

Review on Tuberculosis

Devansh K Mehta

View PDFchevron_right

A Recent Review on Tuberculosis and Its Treatment

Kumud Upadhyaya

International journal of research in pharmacy and chemistry, 2019

View PDFchevron_right

Guidelines for the management of drug-resistant tuberculosis

Jacques Grosset

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1998

View PDFchevron_right

Trend and determinants of tuberculosis treatment outcome in a tertiary hospital in Southeast Nigeria

Azuka Adeke

Journal of Infection and Public Health, 2019

View PDFchevron_right

Extensively Drug-Resistant Tuberculosis, Pakistan

Babar Malik

Emerging Infectious Diseases, 2010

View PDFchevron_right

The return of tuberculosis

Richard Wenzel

Diagnostic Microbiology and Infectious Disease, 1999

View PDFchevron_right

Tuberculosis and HIV: Renewed Challenge

Marcus Conde

Memórias do Instituto Oswaldo Cruz, 1998

View PDFchevron_right

Tuberculosis treatment adherence and fatality in Spain

Martí Casals

Respiratory Research, 2009

View PDFchevron_right

Tuberculosis elimination: theory and practice in Europe

G. Migliori

European Respiratory Journal, 2014

View PDFchevron_right

Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis

Dr Tsegahun Manyazewal

Infectious Diseases of Poverty, 2016

View PDFchevron_right

Movement of Tuberculosis Patients and the Failure to Complete Antituberculosis Treatment

Janet Mohle-Boetani

American Journal of Respiratory and Critical Care Medicine, 1998

View PDFchevron_right

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

H Getahun

European Respiratory Journal, 2011

View PDFchevron_right

Treatment Practices, Outcomes, and Costs of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, United States, 2005–2007

Suzanne Marks

Emerging Infectious Diseases, 2014

View PDFchevron_right

Outcomes of Multidrug-Resistant Tuberculosis among Binational Cases in El Paso, Texas

priyanka boppe

American Journal of Tropical Medicine and Hygiene, 2010

View PDFchevron_right

Tuberculosis and nutrition

Suman Vishvkarma

Lung India, 2009

View PDFchevron_right

Prevalence and evolution of Mycobacterium tuberculosis infection in tuberculosis case contacts

ELAINE GONÇALVES ALVES

Revista da Sociedade Brasileira de Medicina Tropical, 2015

View PDFchevron_right

Tuberculosis and malignancy

Petros Kopterides

QJM: An International Journal of Medicine, 2010

View PDFchevron_right

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

Jai Mullerpattan

International Journal of Infectious Diseases, 2019

View PDFchevron_right

Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007

Ibrahim Abubakar

JAMA, 2008

View PDFchevron_right

New regimens for reducing the duration of treatment of drug-susceptible pulmonary tuberculosis

Marcus Conde

Drug Development Research, 2011

View PDFchevron_right

Tuberculosis in Patients Receiving Antiretroviral Treatment: Incidence, Risk Factors, and Prevention Strategies

Ian Sanne

JAIDS Journal of Acquired Immune Deficiency Syndromes, 2011

View PDFchevron_right

Feasibility and Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis: A Cohort Study in the Philippines

Katherine Floyd

PLoS Medicine, 2006

View PDFchevron_right

The Infectiousness of Tuberculosis Patients Coinfected with HIV

Marcos Ñavincopa

PLoS Medicine, 2008

View PDFchevron_right

Tuberculosis; Relapse in Interrupted Antituberculous Therapy

Muhammad Abdur Rehman khadam, Awais Iqbal

THE PROFESSIONAL MEDICAL JOURNAL, 2017

View PDFchevron_right

Treatment of Latent Tuberculosis Infection in Patients Aged ≥35 Years

Andrea Cruz

Clinical Infectious Diseases, 2000

View PDFchevron_right

Scaling up interventions to achieve global tuberculosis control: Progress and new developments

H Getahun

2012

View PDFchevron_right

The Medical Research Council and treatments for tuberculosis before streptomycin

Linda Bryder

Journal of the Royal Society of Medicine, 2014

View PDFchevron_right